Neuroscience News and Research

RSS

Olympus to host fifth annual neuroimaging symposium in conjunction with 2014 annual meeting of the Society for Neuroscience

Olympus is hosting its fifth annual neuroimaging symposium in conjunction with the 2014 annual meeting of the Society for Neuroscience (SfN) on Monday, November 17 at 6:30pm in Washington DC. The Olympus Neuroimaging Symposium and reception will be held at the Marriott Marquis Washington, DC, 901 Massachusetts Avenue NW, in the Capitol and Congress ballrooms. It is open to all media and registered SfN attendees.

From Evident Corporation - Life Sciences 10 Nov 2014

Living with multiple sclerosis (MS): an interview with Gretchen Rubin and Megan Weigel

Multiple sclerosis, or MS, is a chronic, often disabling disease of the central nervous system, which is made up of the brain, spinal cord, and optic nerves. Symptoms may be mild, moderate, or severe, ranging from numbness in the limbs to paralysis or loss of vision. Approximately 400,000 Americans are living with MS.

9 Nov 2014

Johnson & Johnson completes acquisition of Alios BioPharma

Johnson & Johnson today announced the completion of the acquisition of Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for a total purchase price of approximately $1.75 billion in cash.

8 Nov 2014

Applying lessons learnt from failed Alzheimer's studies for future research

Disappointing results in clinical Alzheimer's studies discourage doctors and scientists from continuing their research into ɣ-secretases and a possible treatment against Alzheimer's disease. In the prestigious journal Cell, the Alzheimer's expert Bart De Strooper (VIB-KU Leuven) argues that these studies are not pointless, but merely indicate what the next steps should be for the Alzheimer's research.

7 Nov 2014

Salk Institute researchers heal injured hearts of living mice

Researchers at the Salk Institute have healed injured hearts of living mice by reactivating long dormant molecular machinery found in the animals' cells, a finding that could help pave the way to new therapies for heart disorders in humans.

7 Nov 2014

U-M researchers show how neurons perform multiple functions

Researchers at the University of Michigan have shown how a single neuron can perform multiple functions in a model organism, illuminating for the first time this fundamental biological mechanism and shedding light on the human brain.

6 Nov 2014

Johns Hopkins study suggests ways to avoid choking under pressure

Everyone knows the scene: a basketball player at the free throw line, bouncing the ball as he concentrates on the basket. It’s a tight game, and his team needs this point. He regularly makes baskets from much farther away while avoiding defenders, but now, when all is calm, he chokes and misses the basket, and his team loses. Recent research from The Johns Hopkins University suggests that in situations like this, performance depends on two factors: the framing of the incentive in terms of a loss or a gain, and a person’s aversion to loss.

6 Nov 2014

Study looks at new diagnostic, treatment approaches to neurological conditions

Despite great advances in understanding how the human brain works, psychiatric conditions, neurodegenerative disorders, and brain injuries are on the rise. Progress in the development of new diagnostic and treatment approaches appears to have stalled. In a special issue of the Cell Press journal Neuron, experts look at the challenges associated with "translational neuroscience," or efforts to bring advances in the lab to the patients who need them.

6 Nov 2014

Commonly prescribed drugs for arthritis and pain may increase risk of death from stroke

Commonly prescribed, older drugs for arthritis and pain may increase the risk of death from stroke, according to a study published in the November 5, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology. Stroke is the fourth leading cause of death in the United States, according to the Centers for Disease Control and Prevention.

5 Nov 2014

UTSA professor selected to receive NSF grant to study complex brain processes

Fidel Santamaria, associate professor of biology in the UTSA College of Sciences, is one of 36 researchers in the nation selected to receive a two-year $300,00 National Science Foundation (NSF) Early Concept Grant for Exploratory Research (EAGER). The funding supports President Obama's BRAIN Initiative, a federal effort to support researchers to create new technology that will demystify complex brain processes.

5 Nov 2014

New technology could revolutionise the way medical staff treat people with degenerative condition

A pioneering piece of technology will allow users to experience the world through the eyes of a person with Young-Onset Parkinson's disease- which could revolutionise the way carers and medical staff treat people with the degenerative condition.

5 Nov 2014

New statistical test can help doctors locate seizures, make surgery more effective

A new statistical test that looks at the patterns of high-frequency network activity flow from brain signals can help doctors pinpoint the exact location of seizures occurring in the brain and make surgery more effective, according to researchers at Georgia State University and Emory University School of Medicine.

5 Nov 2014

Loyola study finds radiation as a risk factor for young people with meningioma

In people under age 30, radiation is a risk factor for a type of brain tumor called a meningioma, a Loyola University Medical Center study has found.

4 Nov 2014

AstraZeneca, Pharmacyclics partner to evaluate efficacy of IMBRUVICA for solid tumors

AstraZeneca and Pharmacyclics, Inc. today announced that they have entered into a clinical trial collaboration to evaluate a novel combination therapy targeting solid tumors.

4 Nov 2014

Douglas Mental Health University Institute researcher wins 2014 Wilder-Penfield prize

The Douglas Mental Health University Institute is proud to announce that its researcher and neurobiologist, Michael Meaney, C.M., Ph.D., C.Q., FRSC, is the 2014 laureate of the prestigious prix Wilder-Penfield.

4 Nov 2014

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Dana-Farber Cancer Institute (Dana-Farber) and Astellas Pharma Inc. today announced a three-year collaboration to research and develop small molecule inhibitors of oncogenic K-Ras for the treatment of cancer, including lung cancer.

4 Nov 2014

Tau proteins spur neuron death in Alzheimer's disease

New research points to tau, not amyloid-beta (Abeta) plaque, as the seminal event that spurs neuron death in disorders such as Alzheimer's disease. The finding, which dramatically alters the prevailing theory of Alzheimer's development, also explains why some people with plaque build-up in their brains don't have dementia.

3 Nov 2014

Study identifies new targets for developing novel treatment for alcohol dependence

Bacteria in the gastrointestinal tract fulfill many vital functions and are critical for digestion. Yet, these same bacteria can induce strong inflammatory responses by the immune system if they penetrate the gut and enter the bloodstream.

31 Oct 2014

Krembil researchers potentially discover major cause of dementia

Researchers at the Krembil Neuroscience Centre have potentially discovered a major cause of dementia. In this type of dementia, there is damage to the white matter (nerve fibres) of the brain apparent on computerized tomography (CT) and magnetic resonance imaging (MRI) scans of older individuals.

31 Oct 2014

Einstein-Montefiore researchers to present latest finding on aging research at GSA 2014

Investigators at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center will present their latest aging research at the Gerontological Society of America's 67th Annual Scientific Meeting.

31 Oct 2014

Neuroscience News and Research

Olympus to host fifth annual neuroimaging symposium in conjunction with 2014 annual meeting of the Society for Neuroscience

Living with multiple sclerosis (MS): an interview with Gretchen Rubin and Megan Weigel

Johnson & Johnson completes acquisition of Alios BioPharma

Applying lessons learnt from failed Alzheimer's studies for future research

Salk Institute researchers heal injured hearts of living mice

U-M researchers show how neurons perform multiple functions

Johns Hopkins study suggests ways to avoid choking under pressure

Study looks at new diagnostic, treatment approaches to neurological conditions

Commonly prescribed drugs for arthritis and pain may increase risk of death from stroke

UTSA professor selected to receive NSF grant to study complex brain processes

New technology could revolutionise the way medical staff treat people with degenerative condition

New statistical test can help doctors locate seizures, make surgery more effective

Loyola study finds radiation as a risk factor for young people with meningioma

AstraZeneca, Pharmacyclics partner to evaluate efficacy of IMBRUVICA for solid tumors

Douglas Mental Health University Institute researcher wins 2014 Wilder-Penfield prize

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Tau proteins spur neuron death in Alzheimer's disease

Study identifies new targets for developing novel treatment for alcohol dependence

Krembil researchers potentially discover major cause of dementia

Einstein-Montefiore researchers to present latest finding on aging research at GSA 2014

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News